Immunocore Holdings plc (IMCR)
Immunocore Holdings plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Immunocore Holdings plc (IMCR) is a Biotechnology company based in GB with a market capitalization of $1.5B. Revenue grew 20.0% year-over-year and free cash flow was negative at -$11.2M. This page tracks IMCR's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
GB · 493 employees · IPO Feb 5, 2021
Valuation
Valuation & price
$29.47as of May 26, 2026· -26.7% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
3.85
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$1.5B
Market cap
20.0%
Revenue growth (YoY)
97.9%
Gross margin
-$11.2M
Free cash flow (USD)
-$820.6M
Net debt
Net cash position
0.7%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 6, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is Immunocore Holdings plc's market cap?
Immunocore Holdings plc (IMCR) has a market capitalization of $1.5B.
What is IMCR's P/E ratio?
A meaningful P/E ratio is not available for IMCR — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is IMCR's price-to-book (P/B) ratio?
IMCR trades at 3.85 times book value per share.
Are insiders buying IMCR stock?
SEC Form 4 filings show no open-market insider buys at Immunocore Holdings plc in the last 90 days (0 sells).
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.